Evidence map›Paper›PMID 41668159›Full record

ArticleCritical care (London, England)2026

Analytical performance of species-targeted quantitative PCR for intra-abdominal candidiasis in critically ill patients: a proof-of-concept post hoc analysis from the pBDG2 multicenter study.

Emmanuel Novy, Arnaud Schaeffer, Maxime Nguyen, Frédéric Dalle, Julien Pottecher, Valérie Letscher-Bru, Guillaume Louis, Charlotte Stephan, Amandine Luc, Marie Machouart and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emmanuel NovyUniversité de Lorraine, CHRU-Nancy, Anesthésie-réanimation et médecine périopératoire, Nancy, 54000, France. e.novy@chru-nancy.fr.ORCID http://orcid.org/0000-0002-4099-8106
Arnaud SchaefferUniversité de Lorraine, CHRU-Nancy, Anesthésie-réanimation et médecine périopératoire, Nancy, 54000, France.
Maxime NguyenUniversité Bourgogne Europe, CHU Dijon Bourgogne, INSERM U.M.R 1231, Department of anesthesiology and intensive care medicine, Center for Translational and molecular Medicine, Lipness Team, Dijon, 21000, France.
Frédéric DalleU.M.R. PAM Univ Bourgogne Europe, Institut Agro Dijon, INRAE, UFR Sciences de Santé, Équipe Aliment, Fermentation, Interaction, Microbiote, AFIM, 21070, Dijon, France.
Julien PottecherService d'Anesthésie-Réanimation & Médecine Péri-Opératoire, Hôpital de Hautepierre, Hôpitaux universitaires de Strasbourg, Strasbourg, 67200, France.
Valérie Letscher-BruLaboratoire de Parasitologie et Mycologie Médicale, Plateau Technique de Microbiologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, 67000, France.
Guillaume LouisService de réanimation polyvalente, CHR Metz-Thionville, Metz, 57000, France.
Charlotte StephanLaboratoire de microbiologie, CHR Metz-Thionville, Metz, 57000, France.
Amandine LucUnité de méthodologie, data management et statistiques, DRCI, CHRU de Nancy, Nancy, 54000, France.
Marie MachouartSIMPA, Université de Lorraine, Vandoeuvre-Lès-Nancy, 54500, France.
Anne DebourgogneSIMPA, Université de Lorraine, Vandoeuvre-Lès-Nancy, 54500, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntra-abdominal candidiasis (IAC) is a severe form of invasive candidiasis that affects critically ill patients and is associated with a high mortality rate and persistent diagnostic delays. Conventional fungal culture from peritoneal fluid remains slow and has insufficient sensitivity. Molecular assays promote early diagnosis, but data from critically ill populations remain scarce.

objectivesWe evaluated the diagnostic performance of the OLM CandID Real-Time PCR assay directly applied to peritoneal fluid samples obtained from a previously established multicenter cohort of critically ill patients with suspected or confirmed IAC.

methodsOLM CandID Real-Time PCR is a quantitative PCR assay for detecting C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, and C. dubliniensis. Binary PCR results were compared with those of fungal culture as the reference standard. Secondary analyses analyzed quantitative PCR values to better understand culture-negative/PCR-positive discordances using ROC-derived cycle threshold (Ct) cutoffs.

resultsFifty-seven patients, mainly with postoperative peritonitis, were included. Among the culture-positive samples, C. albicans was predominant. Using binary interpretation, the PCR achieved 100% sensitivity (95% CI 100–100) and 60% specificity (95% CI 38–81); the positive and negative predictive values were 82% (95% CI 71–93) and 100% (95% CI 100–100), respectively. In the secondary Ct-based analysis, ROC-derived threshold determination was feasible for C. albicans (n = 35) and C. tropicalis (n = 12). For C. albicans and C. tropicalis, the ROC AUC values were 0.92 (95% CI 0.75-1) and 0.90 (95% CI 0.66-1), respectively, and applying the optimal Ct cutoffs (30.75 and 34.63 respectively) yielded 100% specificity and 100% positive predictive value for both species.

conclusionsOLM CandID Real-Time PCR applied directly to peritoneal fluid demonstrated strong analytical performance for the detection of Candida in critically ill patients with suspected IAC. The assay showed high concordance with culture results, supporting its feasibility for rapid microbiological assessment. Discordant PCR-positive/culture-negative results were mainly associated with high Ct values, likely reflecting low fungal burden, detection of non-viable DNA, or analytical over-detection. These findings are exploratory and highlight the need for prospective studies to determine the clinical relevance of quantitative PCR results and their role in guiding antifungal management.

trial registrationThe study was registered with ClinicalTrials.gov (ID number 07005258, first registered on March 6, 2025).

Indexed as

CandidiasisIntraabdominal InfectionsPolymerase Chain ReactionReal-Time Polymerase Chain ReactionCandidaCritical IllnessFemaleHumansMaleMiddle AgedROC CurveSensitivity and SpecificityCritically ill patientDiagnosisIntra-abdominal candidiasisPCR candida

Identifiers

PMID41668159
PMCPMC12990629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.